Emerald Health Therapeutics, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced total revenue was CAD 2.481 million compared to CAD 4.619 million a year ago. Operating income was CAD 2.459 million compared to CAD 13.779 million a year ago. Net loss was CAD 18.862 million compared to CAD 275,000 a year ago. Basic loss per share from continuing operations was CAD 0.1 compared to CAD 0.01 a year ago. For the half year, total revenue was CAD 5.370 million compared to CAD 6.749 million a year ago. Operating income was CAD 9.328 million compared to CAD 23.696 million a year ago. Net loss was CAD 23.596 million compared to CAD 3.719 million a year ago. Basic loss per share from continuing operations was CAD 0.13 compared to CAD 0.03 a year ago.